Femasys (FEMY) News Today $1.64 -0.13 (-7.06%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$1.70 +0.06 (+3.65%) As of 02/21/2025 06:08 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Research Analysts Issue Forecasts for Femasys Q1 EarningsFebruary 15, 2025 | americanbankingnews.comFY2024 Earnings Forecast for Femasys Issued By HC WainwrightFebruary 15, 2025 | americanbankingnews.comHC Wainwright Reiterates Buy Rating for Femasys (NASDAQ:FEMY)February 13, 2025 | americanbankingnews.comFemasys gains UK approval for women's health productsFebruary 11, 2025 | msn.comAnalysts Are Bullish on Top Healthcare Stocks: DENTSPLY SIRONA (XRAY), Femasys (FEMY)February 11, 2025 | markets.businessinsider.comFemasys Announces UK Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic DevicesFebruary 11, 2025 | globenewswire.comFemasys Inc.: Femasys Announces Israeli Regulatory Approvals for FemaSeed for Female Infertility Treatment and Two Diagnostic DevicesFebruary 4, 2025 | finanznachrichten.deFemasys announces Israeli regulatory approvals for FemaSeed treatmentFebruary 4, 2025 | markets.businessinsider.comFemasys Announces Israeli Regulatory Approvals for FemaSeed® for Female Infertility Treatment and Two Diagnostic DevicesFebruary 4, 2025 | finance.yahoo.comFemasys announces notices of intention to grant 2 European patent applicationsJanuary 31, 2025 | markets.businessinsider.comFemasys Inc.: Femasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth ControlJanuary 30, 2025 | finanznachrichten.deFemasys Announces Notices of Intention to Grant for Two New European Patent Applications Covering Use of FemBloc Permanent Birth ControlJanuary 30, 2025 | globenewswire.comFemasys Announces Notice of Allowance for New U.S. Patent Application Covering Use of FemaSeed® for Female Infertility TreatmentJanuary 16, 2025 | globenewswire.comFemasys’s Strategic Partnerships and Market Expansion Drive Buy RatingDecember 5, 2024 | markets.businessinsider.comFemasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeedDecember 4, 2024 | theglobeandmail.comThe Latest Analyst Ratings For FemasysNovember 27, 2024 | benzinga.comFemasys announces peer-reviewed data from FemaSeed ITI in JGRMNovember 27, 2024 | markets.businessinsider.comBuy Recommendation for Femasys Driven by Promising FemaSeed Study Results and Market PotentialNovember 27, 2024 | markets.businessinsider.comFemasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility TreatmentNovember 26, 2024 | globenewswire.comFemasys’s Strategic Growth: Innovative Product Launches and Expansions in Women’s HealthNovember 15, 2024 | markets.businessinsider.comPromising Outlook for Femasys Amid Strategic Partnerships and Product AdvancementsNovember 13, 2024 | markets.businessinsider.comFemasys price target lowered to $8 from $10 at ChardanNovember 13, 2024 | msn.comFemasys’s Strong U.S. Launch and International Expansion Drive Buy RatingNovember 13, 2024 | markets.businessinsider.comFemasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate UpdateNovember 12, 2024 | globenewswire.comFemasys to Exhibit at the Annual AAGL 2024 Global ConferenceNovember 8, 2024 | markets.businessinsider.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 2, 2024 | theglobeandmail.comFemasys issued U.S. patent covering FemBloc deviceNovember 2, 2024 | msn.comFemasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth ControlNovember 1, 2024 | globenewswire.comFemasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeedOctober 31, 2024 | finance.yahoo.comStrategic Partnerships and Market Potential Drive Positive Outlook for FemaSeed Amidst RisksOctober 31, 2024 | markets.businessinsider.comFemasys announces partnership with Boston IVFOctober 31, 2024 | markets.businessinsider.comFemasys Advances in Women’s Health InnovationOctober 29, 2024 | markets.businessinsider.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education ProgramOctober 10, 2024 | finance.yahoo.comFemasys to Exhibit at ASRM 2024 and Participate in the Congress' KEEPR Education ProgramOctober 10, 2024 | globenewswire.comFemasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | markets.businessinsider.comFemasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility TreatmentsOctober 2, 2024 | globenewswire.comFemasys Announces Infertility Clinic Customers from Coast to CoastSeptember 18, 2024 | globenewswire.comFemasys’s Strategic Expansion and Market Potential Bolster Buy RatingSeptember 13, 2024 | markets.businessinsider.comFemasys Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)September 12, 2024 | benzinga.comFemasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish MarketSeptember 11, 2024 | globenewswire.comFemasys Receives 510(k) Clearance From FDA To Market FemChec For Fallopian Tube DiagnosisSeptember 10, 2024 | markets.businessinsider.comFemasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube CheckSeptember 9, 2024 | globenewswire.comFemasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual MeetingSeptember 5, 2024 | markets.businessinsider.comFemasys to Exhibit at The Canadian Fertility and Andrology Society's 70th Annual MeetingSeptember 5, 2024 | globenewswire.comFemasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 3, 2024 | globenewswire.comFemasys Inc.: Femasys Announces CE Mark and Canadian Approval for FemVue MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | finanznachrichten.deFemasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment SolutionAugust 29, 2024 | globenewswire.comFemasys Hosts Congresswoman Lucy McBath at Georgia HeadquartersAugust 27, 2024 | globenewswire.comFemasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate UpdateAugust 8, 2024 | globenewswire.com Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address FEMY Media Mentions By Week FEMY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FEMY News Sentiment▼-0.040.60▲Average Medical News Sentiment FEMY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FEMY Articles This Week▼51▲FEMY Articles Average Week Get Femasys News Delivered to You Automatically Sign up to receive the latest news and ratings for FEMY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sight Sciences News Jin Medical International News Neuronetics News LENSAR News electroCore News Pro-Dex News Edap Tms News FONAR News TELA Bio News Milestone Scientific News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FEMY) was last updated on 2/22/2025 by MarketBeat.com Staff From Our Partners[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Femasys Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Femasys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
